Literature DB >> 6062992

Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.

P Hudgson, D Gardner-Medwin, R J Pennington, J N Walton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6062992      PMCID： PMC496217          DOI： 10.1136/jnnp.30.5.416

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  13 in total

1.  SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY.

Authors:  J STEPHENS; E LEWIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-04       Impact factor: 10.154

2.  [The transaminase activity of the whole blood and serum during muscular effort].

Authors:  J POORTMANS; J J S'JONGERS; A THYS
Journal:  Rev Fr Etud Clin Biol       Date:  1963-02

3.  Effect of physical exercise on some enzymes in the serum.

Authors:  P I HALONEN; A KONTTINEN
Journal:  Nature       Date:  1962-03-10       Impact factor: 49.962

4.  [Progressive muscular dystrophy. III. Serum enzymes in muscular dystrophy in childhood].

Authors:  U AEBI; R RICHTERICH; H STILLHART; J P COLOMBO; E ROSSI
Journal:  Helv Paediatr Acta       Date:  1961-12

5.  Serum enzymes.

Authors:  K S HENLEY; E SCHMIDT; F W SCHMIDT
Journal:  JAMA       Date:  1960-10-22       Impact factor: 56.272

6.  [Study of serum creatine kinase in myopathic patients and their families].

Authors:  J C DREYFUS; G SCHAPIRA; J DEMOS
Journal:  Rev Fr Etud Clin Biol       Date:  1960-04

7.  Serum enzymes and genetic carriers in muscular dystrophy.

Authors:  C S CHUNG; N E MORTON; H A PETERS
Journal:  Am J Hum Genet       Date:  1960-03       Impact factor: 11.025

8.  Studies on human muscular dystrophy with particular reference to methods of carrier detection.

Authors:  J N Walton; R J Pennington
Journal:  Ann N Y Acad Sci       Date:  1966-09-09       Impact factor: 5.691

9.  Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786
View more
  8 in total

1.  Race-gender differences in serum creatine kinase activity: a study among South Africans.

Authors:  R F Gledhill; C A Van der Merwe; M Greyling; M M Van Niekerk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

2.  Cerebrospinal fluid creatine kinase in acutely psychotic patients.

Authors:  W A Martin; R E Garey; R G Heath
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

3.  [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].

Authors:  C M Büsing; H Heyck; G Laudahn
Journal:  Klin Wochenschr       Date:  1969-10-15

4.  Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection.

Authors:  D Gardner-Medwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-04       Impact factor: 10.154

Review 5.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy.

Authors:  F H Herrmann; A Spiegler; G Wiedemann
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

Review 7.  Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy.

Authors:  J Davoodi; C D Markert; K A Voelker; S M Hutson; Robert W Grange
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-12-13       Impact factor: 1.784

8.  Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.

Authors:  R C Hughes; D C Park; M E Parsons; M D O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-10       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.